CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 9, October 2012
AFRICA
511
2003;
26
(2): 141–144.
DOI: 10.1053/ejvs.2002.1974.
25.
Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilation and
stent implantation for treatment of femoropopliteal arterial disease:
meta-analysis.
Radiology
2001;
221
(1): 137–145.
26.
Kim JS, Kang TS, Ahn CM, Ko YG, Choi D, Jang Y,
et al.
Efficacy
of subintimal angioplasty/stent implantation for long, multisegmen-
tal lower limb occlusive lesions in patients unsuitable for surgery.
J
Endovasc Ther
2006;
13
(4): 514–521.
DOI: 10.1583/05-1798MR.1.
27.
Desgranges P, Boufi M, Lapeyre M, Tarquini G, Van Laere O, Losy F,
et al
.
Subintimal angioplasty: feasible and durable.
Eur JVasc Endovasc
2004;
28
(2): 138–141.
DOI: 10.1016/j.ejvs.2004.02.020.
28.
Matoba S, Matsubara H. Therapeutic angiogenesis for peripheral artery
diseases by autologous bone marrow cell transplantation.
Curr Pharm
Des
2009;
15
(24): 2769–2777.
29.
Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy
in peripheral artery disease. A critical appraisal.
Thromb Haemost
2010;
103
(4): 696–709.
DOI: 10.1160/TH09-10-0688.
30.
Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial
disease using stem and progenitor cell therapy.
J Vasc Surg
2011;
53
(2):
445–453.
DOI: 10.1016/j.jvs.2010.08.060.
31.
Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M,
Yoshikawa J. Circulating monocytes and in-stent neointima after coro-
nary stent implantation.
J Am Coll Cardiol
2004;
43
(1): 18–23.
DOI:
10.1016/
j.jacc.2003.08.026.
32.
Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T,
et
al
.
Hematopoietic stem cells differentiate into vascular cells that
participate in the pathogenesis of atherosclerosis.
Nat Med
2002;
8
(4):
403–409.
DOI: 10.1038/nm0402-403.
33.
Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B,
et al
.
Abundant progenitor cells in the adventitia contribute to atherosclero-
sis of vein grafts in ApoE-deficient mice.
J Clin Invest
2004;
113
(9):
1258–1265.
DOI: 10.1172/JCI19628.
34.
Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW,
et al
.
Stem cell factor deficiency is vasculoprotective: unraveling a
new therapeutic potential of imatinib mesylate.
Circ Res
2006;
99
(6):
617–625.
DOI: 10.1161/01.RES.0000243210.79654.fd.
35.
Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T,
et al
.
Mobilization of CD34-positive bone marrow-derived cells after coro-
nary stent implantation: impact on restenosis.
Circulation
2007;
115
(5):
553–561.
DOI: 10.1161/CIRCULATIONAHA.106.621714.
36.
Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of siroli-
mus on circulating vascular progenitor cells.
Circulation
2005;
111
(7):
926–931.
DOI: 10.1161/01.CIR.0000155612.47040.17.
37.
Berman JW, Kazimi M, Ma H. Development of the atherosclerotic
plaque. In: Brown DL, ed.
Cardiovascular Plaque Rupture
.
City
:
Marcel Dekker, 2002: 1–43.
38.
Buemi M, Allegra A, Aloisi C, Corica F, Alonci A, Ruello A,
et al
.
Cold
pressor test raises serum concentrations of ICAM-1, VCAM-1, and
E-Selectin in normotensive and hypertensive patients.
Hypertension
1997;
30
(4): 845–847.
39.
Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M,
et al
.
Circulating vascular cell adhesion molecule-1 correlates with the
extent of human atherosclerosis in contrast to circulating intercellular
adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.
Arterioscler Thromb Vasc Biol
1997;
17
(3): 505–512.
40.
Yasukawa H, Imaizumi T, Matsuoka H, Nakashima A, Morimatsu M.
Inhibition of intimal hyperplasia after balloon injury by antibodies to
intercellular adhesion molecule-1 and lymphocyte function–associated
antigen-1.
Circulation
1997;
95
(6): 1515–1522.
41.
Hayashi S, Watanabe N, Nakazawa K, Suzuki J, Tsushima K, Tamatani
T
,
et al
.
Roles of P-selectin in inflammation, neointimal formation, and
vascular remodeling in balloon-injured rat carotid arteries.
Circulation
2000;
102
(14): 1710–1717.
42.
Shimazawa M, Kondo K, Hara H, Nakashima M, Umemura K.
Sulfatides, L- and P-selectin ligands, exacerbate the intimal hyperplasia
occurring after endothelial injury.
Eur J Pharmacol
2005;
520
(1–3):
118–126.
DOI: 10.1016/j.ejphar.2005.06.039.
43.
Riou S, Mees B, Esposito B, Merval R, Vilar J, Stengel D,
et
al.
High Pressure promotes monocyte adhesion to the vascu-
lar wall.
Circ Res
2007;
100
(8): 1226–1233.
DOI: 10.1161/01.
RES.0000265231.59354.2c.
44.
Mehrhof FB, Schmidt-Ullrich R, Dietz R, Scheidereit C. Regulation
of vascular smooth muscle cell proliferation: Role of NF-{kappa}
B revisited.
Circ Res
2005; 96(9): 958–964.
DOI: 10.1161/01.
RES.0000166924.31219.49.
45.
Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ. IKKbeta-dependent
NF-kappaB pathway controls vascular inflammation and intimal hyper-
plasia.
FASEB J
2005;
19
(10): 1293–1295.
DOI: 10.1096/fj.04-2645fje.
46.
Shimazawa M, Watanabe S, Kondo K, Hara H, Nakashima M,
Umemura K. Neutrophil accumulation promotes intimal hyperplasia
after photochemically induced arterial injury in mice.
Eur J Pharmacol
2005;
520
(1–3): 156–163.
DOI: 10.1016/j.ejphar.2005.07.031.
47.
Foulds S, Galustian C, Mansfield AO, Schachter M. Transcription
factor NF kappa B expression and postsurgical organ dysfunction.
Ann
Surg
2001;
233
(1): 70–78.
48.
Huang B, Dreyer T, Heidt M, Yu JCM, Philipp M, Hehrlein FW,
et al
.
Insulin and local growth factor PDGF induce intimal hyperplasia in
bypass graft culture models of saphenous vein and internal mammary
artery.
Eur J Cardio-Thorac
Surg
2002;
21
(6): 1002–1008.
DOI:
10.1016/
S1010-7940(02)00111-2.
49.
Bhardwaj S, Roy H, Heikura T, Ylä-Herttuala S. VEGF-A, VEGF-D
and VEGF-DdeltaNdeltaC induced intimal hyperplasia in carotid arter-
ies.
Eur J Clin Invest
2005;
35
(11): 669–676.
DOI: 10.1111/j.1365-
2362.2005.01555.
x.
50.
Cheema AN, Hong T, Nili N, Segev A, Moffat JG, Lipson KE,
et al
.
Adventitial microvessel formation after coronary stenting and the
effects of SU11218, a tyrosine kinase inhibitor.
J Am Coll Cardiol
2006;
47
(5): 1067–1075.
DOI: 10.1016/j.jacc.2005.08.076.
51.
Kwon HM, Sangiorgi G, Ritman EL, Lerman A, McKenna C, Virmani
R,
et al
.
Adventitial vasa vasorum in balloon-injured coronary arter-
ies: Visualization and quantitation by a microscopic three-dimensional
computed tomography technique.
J Am Coll Cardiol
1998;
32
(7):
2072–2079.
DOI: 10.1016/S0735-1097(98)00482-3.
52.
Simons M. VEGF and restenosis: The rest of the story.
Arterioscler
Thromb Vasc Biol
2009;
29
(4): 439–440.
DOI: 10.1161/
ATVBAHA.109.183970.
53.
Xu X, Lu H, Lin H, Ni M, Sun H, Li C,
et al.
Lymphangiogenesis
promotes inflammation and neointimal hyperplasia after adventitia
removal in the rat carotid artery.
Int J Cardiol
2009;
134
(3): 426–427.
DOI: 10.1016/j.ijcard.2007.12.098.
54.
Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P,
et al
.
VEGF-B
inhibits apoptosis via VEGFR-1-mediated suppression of the expres-
sion of BH3-only protein genes in mice and rats.
J Clin Invest
2008;
118
(3): 913–923.
DOI: 10.1172/JCI33673.
55.
Li X, Lee C, Tang Z, Zhang F, Arjunan P, Li Y,
et al
.
VEGF-B: a
survival, or an angiogenic factor?
Cell Adh Migr
2009;
3
(4): 322–327.
56.
Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I,
et
al
.
Vascular endothelial growth factor B controls endothelial fatty acid
uptake.
Nature
2010;
464
(7290): 917–921.
DOI: 10.1038/nature08945.
57.
Stefanadis C, Toutouzas K, Stefanadi E, Lazaris A, Patsouris E,
Kipshidze N. Inhibition of plaque neovascularization and intimal
hyperplasia by specific targeting vascular endothelial growth factor
with bevacizumab-eluting stent: An experimental study.
Atherosclerosis
2007;
195
(2): 269–276.
DOI: 10.1016/j.atherosclerosis.2006.12.034.
58.
Rzucidlo EM. Signaling pathways regulating vascular smooth muscle
cell differentiation.
Vascular
2009;
17
(
Suppl 1): S15–20.
